Temporal trend in the use of hysteroscopic vs laparoscopic sterilization and the characteristics of commercially insured and Medicaid-insured females in the US who have had the procedures
Authors Carney P, Lin J, Xia F, Law A
Received 5 February 2016
Accepted for publication 17 March 2016
Published 10 May 2016 Volume 2016:8 Pages 137—144
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Fredrick Rosario Joseph
Peer reviewer comments 3
Editor who approved publication: Professor Elie Al-Chaer
Patricia I Carney,1 Jay Lin,2 Fang Xia,3 Amy Law3
1Medical Affairs, Bayer HealthCare Pharmaceuticals, Inc, Whippany, 2Novosys Health, Green Brook, 3Health Economics and Outcomes Research, Bayer HealthCare Pharmaceuticals, Inc., Whippany, NJ, USA
Purpose: Limited research has examined the factors associated with female permanent contraception procedures. This study evaluated the temporal trend in the use of hysteroscopic sterilization (HS) vs laparoscopic sterilization (LS) and characteristics of commercially insured and Medicaid-insured women in the US who have had the procedures.
Methods: Women aged 15–49 years with claims for HS and LS procedures were identified from two MarketScan databases, one consisting of commercial claims and the other Medicaid claims, during the time period of January 1, 2003 to December 31, 2012 and January 1, 2006 to December 31, 2011, respectively. Proportions and characteristics of women who underwent HS or LS procedures were determined. Multivariable logistic regressions were used to identify characteristics associated with the use of HS vs LS.
Results: Commercially insured women who had HS (n=32,012) vs LS (n=64,725) were slightly older (37.2 years vs 36.4 years, respectively, P<0.001) but had similar Charlson Comorbidity Index scores. Among commercially insured women, those who had a sterilization procedure during 2008–2012 were more likely to undergo HS (odds ratio: 7.1, P<0.001) than those who had a sterilization procedure during 2003–2007. Medicaid-insured women who had HS (n=2,001) were also slightly older than women who had LS (n=12,523; 30.1 years vs 28.8 years, respectively, P<0.001) but had a higher mean Charlson Comorbidity Index score (0.32 vs 0.25, respectively, P<0.001). Among Medicaid-insured women, the likelihood of having HS vs LS increased 3.3-fold (P<0.001) in years 2009–2011 compared to years 2006–2008. Among both populations, older age, obesity, and the use of oral contraceptives within the previous 12 months were associated with having HS vs LS.
Conclusion: Among both commercially insured and Medicaid-insured women, the likelihood of having HS vs LS increased over time.
Keywords: contraception procedures, hysteroscopic sterilization, laparoscopic sterilization
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]